Combination of DSF/Cu and chemotherapeutic drugs sensitizes breast cancer (BC) cells and their stem cells by targeting various cellular and signaling mechanisms
The combination of DSF/Cu and chemotherapeutic drugs sensitizes breast cancer (BC) cells and their stem cells by targeting various cellular and signaling mechanisms. (a) DSF sensitizes BC cells by inhibiting p-glycoprotein (Pgp) or inducing apoptosis and autophagy through the activation of reactive oxygen species (ROS). It also sensitizes BC cells by inhibiting epithelial-to-mesenchymal transition (EMT) and stemness via the targeting of NF-kB-dependent TGF. DSF further sensitizes BC cells by inhibiting ERK/Snail-dependent mammosphere formation and inhibiting BC cell proliferation by blocking the Akt pathway. Moreover, DSF enhances antitumor immunity by inhibiting myeloid-derived suppressor cells or activating CAR-T cells. (b) The combination of DSF/Cu with paclitaxel (PTX), doxorubicin (DOX), cisplatin (CIS), and 6-thioguanine (6-TG) triggers ROS, which in turn induces apoptosis by upregulating BAX expression via the JNK/MAPK signaling pathway in breast cancer stem cells (BCSCs). ROS also induces autophagy by activating FOXP3 signaling and reduces mammosphere formation in BCSCs by inhibiting ALDH1 via targeting transcription factors SOX2 and OCT4. Additionally, ROS inhibits the proliferation of BCSCs by inhibiting survivin via targeting STAT3 or inducing cell cycle arrest by causing DNA damage. Furthermore, ROS inhibits BCSCs within the tumor by inducing ferroptosis by triggering mitochondrial atrophy
Publication
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing (2024) RamaRao Malla, et al. Cancers (Basel). 2024 Apr;16(8). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Pgp | PGP | ncbigene_symbol | PGP | 283871 |
| Homo sapiens | Primates | Pgp | PGP | ncbigene_synonym | ABCB1 | 5243 |
| Homo sapiens | Primates | Pgp | PGP | ncbigene_synonym | PGPEP1 | 54858 |
| Homo sapiens | Primates | BAX | BAX | ncbigene_symbol | BAX | 581 |
| Homo sapiens | Primates | FOXP3 | FOXP3 | ncbigene_symbol | FOXP3 | 50943 |
| Homo sapiens | Primates | JNK | JNK | ncbigene_synonym | MAPK8 | 5599 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK1 | 5594 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK14 | 1432 |
| Homo sapiens | Primates | ALDH1 | ALDH1 | ncbigene_synonym | ALDH1A1 | 216 |
| Homo sapiens | Primates | OCT | OCT | ncbigene_synonym | PLXNA2 | 5362 |
| Homo sapiens | Primates | NF-kB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | EMT | EMT | ncbigene_synonym | ITK | 3702 |
| Homo sapiens | Primates | EMT | EMT | ncbigene_synonym | SLC22A3 | 6581 |
| Homo sapiens | Primates | CD44/ | CD44 | ncbigene_symbol | CD44 | 960 |
| Homo sapiens | Primates | CD24 | CD24 | ncbigene_symbol | CD24 | 100133941 |
| Homo sapiens | Primates | Snail | SNAIL | ncbigene_synonym | SNAI1 | 6615 |
| Homo sapiens | Primates | ERK/Snail | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | STAT3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | Akt | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | CIS | CIS | ncbigene_synonym | CISH | 1154 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| ROS | ROS | chebi:26523 | ||
| 6-TG | 6-TG | 6-thioguanine | chebi:9555 | |
| PTX | PTX | (2S,3R,5R,6E,8R,9S)-10-[(2R,3R,4R,5S,6R)-6-{(1S,2R,3S,4S,5R,11S)-12-[(1R,3S,5S,7R)-5-{(8S)-9-[(2R,3R,4R,5R,6S)-6-{(2S,3S,4E,6S,9R,10R)-10-[(2S,4R,5S,6R)-6-{(2R,3R)-4-[(2R,3S,4R,5R,6S)-6-{(2S,3Z,5E,8R,9S,10R,12Z,17S,18R,19R,20R)-21-[(2R,3R,4R,5S,6R)-6-{(1Z,3R,4R)-5-[(1S,3R,5R,7R)-7-{2-[(2R,3R,5S)-5-(aminomethyl)-3-hydroxytetrahydrofuran-2-yl]ethyl}-2,6-dioxabicyclo[3.2.1]octan-3-yl]-3,4-dihydroxypent-1-en-1-yl}-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]-2,8,9,10,17,18,19-heptahydroxy-20-methyl-14-methylenehenicosa-3,5,12-trien-1-yl}-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]-2,3-dihydroxybutyl}-4,5-dihydroxytetrahydro-2H-pyran-2-yl]-2,6,9,10-tetrahydroxy-3-methyldec-4-en-1-yl}-3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl]-8-hydroxynonyl}-1,3-dimethyl-6,8-dioxabicyclo[3.2.1]octan-7-yl]-1,2,3,4,5-pentahydroxy-11-methyldodecyl}-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]-2,5,8,9-tetrahydroxy-N-{(1E)-3-[(3-hydroxypropyl)amino]-3-oxoprop-1-en-1-yl}-3,7-dimethyldec-6-enamide | chebi:146207 | |
| DSF | DSF | chebi:81585 | ||
| ROS | ROS | chebi:26523 | ||
| DNA | DNA | deoxyribonucleic acids | chebi:16991 |